2022
DOI: 10.1007/s12149-022-01773-1
|View full text |Cite
|
Sign up to set email alerts
|

18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 28 publications
2
6
0
Order By: Relevance
“…In this study, SUV max emerged as an independent risk predictor for predicting STAS. Higher SUV max values indicate stronger metabolic activity and tumor aggressiveness, correlating with an increased positive rate of STAS, consistent with findings from prior studies (Wang et al 2020 ; Nishimori et al 2022 ). Subgroup analysis revealed that SUV max was an independent risk predictor for predicting STAS in solid nodular NSCLC.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In this study, SUV max emerged as an independent risk predictor for predicting STAS. Higher SUV max values indicate stronger metabolic activity and tumor aggressiveness, correlating with an increased positive rate of STAS, consistent with findings from prior studies (Wang et al 2020 ; Nishimori et al 2022 ). Subgroup analysis revealed that SUV max was an independent risk predictor for predicting STAS in solid nodular NSCLC.…”
Section: Discussionsupporting
confidence: 90%
“…Wang et al ( 2020 ) demonstrated the value of SUV max and total lesion glycolysis (TLG) as indicators for predicting STAS, achieving a diagnostic accuracy of 71.1% and an area under the curve (AUC) value of 0.759. Nishimori et al ( 2022 ) identified an SUV max cut-off value of 2.48, yielding a sensitivity, specificity, and AUC value of 89.5%, 52.8%, and 0.74, respectively. Few studies have explored predicting STAS based on 18 F-FDG PET/CT metabolic parameters combined with CT features.…”
Section: Introductionmentioning
confidence: 99%
“…Similar to the literature, no signi cant difference was found between patients with and without STAS in terms of age, gender, tumor size, and tumor location [8]. It has even been reported that SUVmax is a valuable indicator for the prediction of STAS in clinical Stage I lung adenocarcinoma [9]. In contrast to these results, we concluded in our study that SUVmax values were not a su cient parameter to predict STAS positivity.…”
Section: Discussionsupporting
confidence: 71%
“…Currently, there are several clinical studies about C/T ratio with STAS and confirmed that the C/T ratio was associated with STAS positive tumors [ 18 , 19 ]. In a previous study, STAS was significantly related to 18F FDG-PET findings, especially SUVmax value [ 20 ] and MTV/CTV ratio [ 21 ]. Kim et al reported that STAS was more common in solid tumors than in part-solid or ground-glass lesions [ 18 ].…”
Section: Discussionmentioning
confidence: 99%